AIAlphaFold Exposes CRISPR-Cas9 Weaknesses: A Pathway to Ultra-Specific Gene Editing
AlphaFold reveals CRISPR-Cas9 off-target weaknesses, enabling the design of ultra-specific gene editing therapies and advanced biosecurity tools.
AIAlphaFold reveals CRISPR-Cas9 off-target weaknesses, enabling the design of ultra-specific gene editing therapies and advanced biosecurity tools.
AICybercrime poses severe risks to AI in biologic drug design, from data poisoning to model theft. Learn how to secure the lab of the future.